Evidence map›Paper›PMID 22361342›Full record

ReviewTrends in endocrinology and metabolism: TEM2012

Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit.

Peter Rotwein

Open access · bronzeAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Inborn errors of regulatory T-cell differentiation and function.The Journal of allergy and clinical immunology · 2025
    Review
  8. Article
  9. Article
  10. Association of theVeterinary sciences · 2023
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. The GH-IGF-1 Axis in Circadian Rhythm.Frontiers in molecular neuroscience · 2021
    Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Peter RotweinDepartment of Biochemistry and Molecular Biology, Oregon Health & Science University, Portland, OR 97239-3098, USA. rotweinp@ohsu.edu
Oregon Health & Science University · US

Funding

Control of IGF-1 Gene Transcription by Growth HormoneR01DK069703 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROTWEIN, PETER S · 2006 to 2014
$2.8M
NIDDK NIH HHS R01 DK069703
6 · The paper itself

Abstract

Growth hormone (GH) and insulin-like growth factor-I (IGF-I) exert powerful influences on somatic growth, metabolism, and tissue repair, and have been implicated in aging and carcinogenesis. Since the formulation of the somatomedin hypothesis over 50 years ago, GH and IGF-I have been linked intimately to one another. Recent studies have established that GH potently stimulates IGF-I gene transcription, and through this mechanism controls production of IGF-I. A key mediator of the GH-IGF-I biosynthetic pathway is the latent transcription factor Stat5b. This review summarizes the potentially complex mechanistic relationship between GH action, Stat5b, and IGF-I gene activation, and suggests that Stat5b may have a broad role in mediating IGF-I gene regulation in response to diverse physiological inputs.

Indexed as

AnimalsGrowth HormoneHumansInsulin-Like Growth Factor IModels, BiologicalSTAT5 Transcription FactorTranscription, GeneticGrowth HormoneInsulin-Like Growth Factor ISTAT5 Transcription Factor

Identifiers

PMID22361342
PMCPMC3313013
OpenAlexW1991207201

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.